The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Methotrexate Orion 10 mg tablets

Orion CorporationPA1327/019/002

Main Information

Trade NameMethotrexate Orion 10 mg tablets
Active SubstancesMethotrexate
Dosage FormTablet
Licence HolderOrion Corporation
Licence NumberPA1327/019/002

Group Information

ATC CodeL01BA Folic acid analogues
L01BA01 methotrexate
L04AX Other immunosuppressants
L04AX03 methotrexate


License statusAuthorised
Licence Issued21/10/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListMethotrexate 10mg Tablets
Interchangeable List CodeIC0098-002-002
Interchangeable List DocumentPDF of Interchangeable List
« Back